"Interleukin-3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A multilineage cell growth factor secreted by LYMPHOCYTES; EPITHELIAL CELLS; and ASTROCYTES which stimulates clonal proliferation and differentiation of various types of blood and tissue cells.
    
			
			
				
				
					
						| Descriptor ID | D007377 | 
					
						| MeSH Number(s) | D12.644.276.374.410.240.400 D12.644.276.374.465.032 D12.776.395.240.400 D12.776.467.374.410.240.400 D12.776.467.374.465.032 D23.529.374.410.240.400 D23.529.374.465.169 | 
					
						| Concept/Terms | Interleukin-3Interleukin-3Interleukin 3IL-3Mast-Cell Colony-Stimulating FactorMultipotential Colony-Stimulating FactorMultipotential Colony Stimulating FactorErythrocyte Burst-Promoting FactorErythrocyte Burst Promoting FactorBurst-Promoting Factor, ErythrocyteBurst Promoting Factor, ErythrocyteColony-Stimulating Factor 2 AlphaColony-Stimulating Factor, Mast-CellColony Stimulating Factor, Mast CellColony-Stimulating Factor, MultipotentialColony Stimulating Factor, MultipotentialEosinophil-Mast Cell Growth-FactorEosinophil Mast Cell Growth FactorHematopoietin-2Hematopoietin 2P-Cell Stimulating FactorP Cell Stimulating Factor
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Interleukin-3".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Interleukin-3".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Interleukin-3" by people in this website by year, and whether "Interleukin-3" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1998 | 0 | 1 | 1 | 
| 1999 | 0 | 1 | 1 | 
| 2000 | 1 | 0 | 1 | 
| 2005 | 0 | 1 | 1 | 
| 2008 | 1 | 1 | 2 | 
| 2009 | 0 | 1 | 1 | 
| 2014 | 1 | 0 | 1 | 
| 2018 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Interleukin-3" by people in Profiles.
						
					
								- 
								Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Clin Lymphoma Myeloma Leuk. 2024 04; 24(4):e130-e137. 
- 
								Translating the biology of ? common receptor-engaging cytokines into clinical medicine. J Allergy Clin Immunol. 2023 02; 151(2):324-344. 
- 
								Interleukin-3, symptoms and cognitive deficits in first-episode drug-na?ve and chronic medicated schizophrenia. Psychiatry Res. 2018 05; 263:147-153. 
- 
								Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia. Schizophr Res. 2016 10; 176(2-3):196-200. 
- 
								Increased IL-3 serum levels in chronic patients with schizophrenia: Associated with psychopathology. Psychiatry Res. 2015 Sep 30; 229(1-2):225-9. 
- 
								Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients. Blood. 2014 Jul 17; 124(3):385-92. 
- 
								Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy. Cancer Immunol Immunother. 2014 Aug; 63(8):835-45. 
- 
								The role of HuR in the post-transcriptional regulation of interleukin-3 in T cells. PLoS One. 2014; 9(3):e92457. 
- 
								ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells. Leukemia. 2010 Apr; 24(4):869-72. 
- 
								Identification of Flightless-I as a substrate of the cytokine-independent survival kinase CISK. J Biol Chem. 2009 May 22; 284(21):14377-85.